Multicentric Castleman's disease (MCD)is an uncommonand often incurable lymphoproliferative disorder. There has been some recent evidence that rare cases of MCDmanifest diffuse lung involvement, but the features in these cases are not well characterized. Wereport just such a biopsy-proven case of MCDwith typical laboratory abnormalities including serum interleukin-6 elevation and characteristic high-resolution CT findings.
Introduction
Castleman's disease (CD) is an uncommonlymphoproliferative disorder characterized by mass lesions that occur most often in the mediastinum (1) . There are two major histologic variants (2, 3) : hyaline-vascular CD, which presents as an asymptomatic mediastinal or hilar mass, and plasma cell CD, which presents with systemic symptomsthat result from the production of interleukin-6 (IL-6) by hyperplastic lymph nodes (4, 5) . Although most cases of plasma cell CD involve mainly the thorax, a generalized form is recognized as multicentric Castleman's disease (MCD) (4, 6) . This form is relatively rare and is characterized by systemic lymphadenopathy, multiple organ involvement, polyclonal hyper globulinemia, elevated erythrocyte sedimentation, increased IL-6, and other nonspecific clinical manifestations such as fever and anemia. In contrast to the localized disease, MCDdoes not benefit from surgical management, and it is often refractory to treatment even with corticosteroid or chemotherapy and immunotherapies with anti-IL-6 or anti-IL-6 receptor monoclonal antibodies (4, 6, 7) . It has been understood recently that MCDoccasionally involves the pulmonary parenchyma, and to our knowledge, a limited number of such cases have been reported as cases of lymphoid interstitial pneumonia (8-10). Here, we report a case of MCDwith diffuse interstitial infiltrates, pathologically proved by video-thoracoscopic lung and mediastinal lymph node biopsy. Wedescribe the characteristic clinical, laboratory, radiographic, and pathologic findings of the disease, as well as successful treatment with corticosteroid and cyclophosphamide leading to 4 years of remission.
Case Report
A 53-year-old HIV-negative Japanese womanhad been in excellent health until 4 months prior to hospitalization for fatigue, dry cough, and continuous low grade fever. Physical examination on admission showedno abnormality except for slightly swollen cervical and axillary lymph nodes and mild splenomegaly. Laboratory tests disclosed increased serum total protein (9.7 g/dl) with hypoalbuminemia (2.9 g/dl) and a normochromic anemia with a HB of ll. showed thickening of the peribronchovascular interstitium, interlobular septa, and poorly defined centrilobular ground glass opacities that were perilymphatic in distribution ( interlobular interstitium than in the alveolar septa (Fig. 2) . Bronchoalveolar lavage showed an increase in the total number of cells (4.81xlO5/ml IU/ml) and HB (13.2 g/dl) had normalized. The mediastinal and hilar lymphadenopathy had resolved completely, and the lung abnormalities were absent except for somelinear opacity at the interstitium (Fig. IB) . During the follow-up period of 48 months, MCDactivity was well controlled, however, the patient had two episodes of skin eruption due to Herpes- corticosteroid therapy including pulse therapy was partially effective with some success to reduce disease activity, however, it failed to achieve complete remission. MCDremitted after cyclophosphamidewas added to corticosteroids, and remission was maintained with low doses of these drugs over a 48-month period. Adding cyclophosphamide to prednisolone was of value to lead to disease remission and reduce the dosage of prednisolone. Particularly with respect to the reduced side effects, the combination of cyclophosphamide and low-dose steroids maybe an attractive regimenfor the treatment of MCD.
